ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,004,177 | -12.4% | 392,866 | -2.1% | 0.00% | 0.0% |
| Q2 2023 | $12,558,874 | +3.8% | 401,242 | -6.5% | 0.00% | 0.0% |
| Q1 2023 | $12,101,770 | -2.4% | 429,293 | -9.5% | 0.00% | -25.0% |
| Q4 2022 | $12,399,626 | +23.1% | 474,536 | +5.2% | 0.00% | +33.3% |
| Q3 2022 | $10,069,000 | -40.8% | 450,911 | -21.0% | 0.00% | -40.0% |
| Q2 2022 | $17,004,000 | +18.9% | 570,792 | +5.0% | 0.01% | +25.0% |
| Q1 2022 | $14,300,000 | +19.9% | 543,551 | +6.0% | 0.00% | +33.3% |
| Q4 2021 | $11,931,000 | -12.5% | 512,928 | +16.0% | 0.00% | 0.0% |
| Q3 2021 | $13,631,000 | -28.0% | 442,004 | -42.8% | 0.00% | -40.0% |
| Q2 2021 | $18,942,000 | +31.9% | 772,481 | +0.5% | 0.01% | +25.0% |
| Q1 2021 | $14,356,000 | +18.4% | 768,554 | +26.4% | 0.00% | 0.0% |
| Q4 2020 | $12,129,000 | +22.5% | 607,978 | +1.8% | 0.00% | +33.3% |
| Q3 2020 | $9,901,000 | +121.0% | 597,496 | +158.7% | 0.00% | +50.0% |
| Q2 2020 | $4,481,000 | -45.4% | 230,968 | -59.4% | 0.00% | -33.3% |
| Q1 2020 | $8,212,000 | +110.8% | 569,505 | +198.2% | 0.00% | +200.0% |
| Q4 2019 | $3,896,000 | -48.6% | 190,949 | -50.9% | 0.00% | -50.0% |
| Q3 2019 | $7,584,000 | -9.3% | 388,677 | +4.8% | 0.00% | 0.0% |
| Q2 2019 | $8,363,000 | -94.7% | 371,031 | -91.4% | 0.00% | -96.2% |
| Q1 2019 | $158,310,000 | +23.4% | 4,338,464 | -0.2% | 0.05% | +8.2% |
| Q4 2018 | $128,288,000 | -31.0% | 4,347,295 | -0.7% | 0.05% | -15.5% |
| Q3 2018 | $185,889,000 | +7.0% | 4,380,047 | +3.8% | 0.06% | 0.0% |
| Q2 2018 | $173,744,000 | -28.8% | 4,221,195 | +0.3% | 0.06% | -36.3% |
| Q1 2018 | $243,902,000 | -11.1% | 4,208,109 | -16.1% | 0.09% | -8.1% |
| Q4 2017 | $274,392,000 | +7.2% | 5,013,552 | -0.4% | 0.10% | +4.2% |
| Q3 2017 | $255,959,000 | -15.7% | 5,034,597 | -3.8% | 0.10% | +1.1% |
| Q2 2017 | $303,531,000 | +2.7% | 5,236,007 | +3.6% | 0.09% | -3.1% |
| Q1 2017 | $295,619,000 | +0.2% | 5,053,331 | -4.8% | 0.10% | -2.0% |
| Q4 2016 | $295,100,000 | -11.3% | 5,309,460 | -25.0% | 0.10% | -13.2% |
| Q3 2016 | $332,760,000 | +5.3% | 7,075,482 | -3.2% | 0.11% | -1.7% |
| Q2 2016 | $315,951,000 | +18.3% | 7,310,307 | -6.4% | 0.12% | +6.4% |
| Q1 2016 | $267,070,000 | -64.9% | 7,811,368 | -18.5% | 0.11% | -64.1% |
| Q4 2015 | $761,024,000 | +26.4% | 9,587,108 | -6.6% | 0.30% | +19.2% |
| Q3 2015 | $602,172,000 | -19.8% | 10,263,709 | -12.0% | 0.26% | -13.3% |
| Q2 2015 | $750,383,000 | +5.4% | 11,662,794 | -0.1% | 0.29% | +6.9% |
| Q1 2015 | $711,776,000 | +3.5% | 11,674,213 | -0.6% | 0.28% | +3.4% |
| Q4 2014 | $688,023,000 | +61.8% | 11,749,024 | +18.4% | 0.27% | +56.5% |
| Q3 2014 | $425,263,000 | -23.3% | 9,919,821 | -9.9% | 0.17% | -22.0% |
| Q2 2014 | $554,224,000 | +34.5% | 11,011,811 | +17.8% | 0.22% | +30.5% |
| Q1 2014 | $412,107,000 | +403.6% | 9,346,939 | +364.4% | 0.17% | +421.9% |
| Q4 2013 | $81,827,000 | +10363.8% | 2,012,482 | +8559.9% | 0.03% | – |
| Q3 2013 | $782,000 | +19.0% | 23,239 | +1.6% | 0.00% | – |
| Q2 2013 | $657,000 | – | 22,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |